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To permit normal postnatal germ cell development, the mammalian testis undergoes a
complex, multi-staged process of descent to the scrotum. Failure of any part of this process
leads to congenital cryptorchidism, wherein the malpositioned testis ﬁnds itself at the
wrong temperature after birth, which leads to secondary germ cell loss and later infertility
and risk of cancer. Recent studies suggest that neonatal gonocytes transform into the
putative spermatogenic stem cells between 3 and 9 months, and this initial postnatal step
is deranged in cryptorchid testes. In addition, it is thought the abnormality high temperature
may also impair apoptosis of remaining gonocytes, allowing some to persist to become the
possible source of carcinoma in situ and malignancy after puberty.The biology of postnatal
germ cell development is of intense interest, as it is likely to be the key to the optimal
timing for orchidopexy.
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INTRODUCTION
The right way to treat undescended testes (UDT) remains to be
solved. Although much is known about the development of the
testes and sperm cells, there is a missing link in our knowl-
edge. It is not known when and how the progenitors of germ
cells transform from neonatal gonocytes into spermatogonia or
spermatic stem cells. Recent research suggests that a critical stage
of sperm cell development may occur in the early postnatal
period. Germ cell development has been studied extensively in
the fetus and at puberty, but not in this postnatal window. We
will propose in this review that knowledge about early postna-
tal germ cell development is crucial for the optimal management
of UDT.
Undescended testes, or cryptorchidism, is a major problem
occurring in about 5% of neonatal boys, with surgery to pull
the testes down to the scrotum (orchidopexy), currently recom-
mended between 6 and 12–18 months (Ritzen et al., 2007; Hutson
et al., 2010). It has been previously shown in numerous studies that
cryptorchidism in the past was associated with a 30–60% risk of
infertility or lack of germcells, and a 5- to 10-fold increase in testic-
ular malignancy. Crucial steps in maturation of gonocytes into the
sperm cell lineage and of sperm cell development could be occur-
ring in this early postnatal period and could be dependent on low
temperature present in the scrotum but lacking in UDT. In addi-
tion, massive cell death should occur in non-maturing gonocytes,
clearing the testis of any undifferentiated, pluripotential neonatal
germ cells, as persisting cells could go on to undergo cell division
and become cancerous. The timing of surgery for orchidopexy
aims to prevent these problems but lacks scientiﬁc evidence. In
this review, we examine the evidence for early postnatal germ cell
development to determine what controls these steps and also to
examine the evidence for early orchidopexy to try and prevent
abnormal germ cell development.
NORMAL EMBRYOLOGY AND POSTNATAL DEVELOPMENT
IN HUMANS
At 5 weeks of gestation, embryonic gonocytes migrate from
the umbilical stalk into the ambisexual gonad. Human sexual
development then begins at 7–8 weeks’ gestation when the SRY
(sex-determining region Y) gene initiates testicular differentiation
with Sertoli cell development (Sinclair, 1994). Cords of Sertoli
cells surround the newly arrived germ cells and the interstitial
cells form Leydig cells and peritubular myoid cells. Müllerian-
inhibiting substance (or anti-Müllerian hormone) (MIS/AMH)
and testosterone synthesis by Sertoli cells and Leydig cells, respec-
tively, trigger regression of Müllerian ducts and preservation of
Wolfﬁan ducts which form epididymis, vas, and seminal vesi-
cles (Wilson et al., 1981; Lee and Donahoe, 1993; Figure 1). The
intra-abdominal fetal testis descends to the scrotum in a complex,
two-stage process that in humans is complete at birth, while in
rodents the second phase occurs in the ﬁrst week after birth (Hut-
son et al., 1997). The regulation of this two-stage process is not
the subject of this review, but interested readers should see some
recent reviews (Ivell and Hartung, 2003; Adham and Agoulnik,
2004; Amann and Veeramachaneni, 2007; Bay et al., 2011).
In baby boys, the temperature of the intra-scrotal testes drops
to 33◦C at birth, with all the testicular enzyme systems read-
justing presumably within a few weeks to this new environment
(Zorgniotti, 1991). Between 2 and 4 months of age pituitary
gonadotropins stimulate a sudden increase in testosterone pro-
duction which peaks at about 3–6 months, before it wanes and
becomes almost negligible until the onset of puberty. This brief
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FIGURE 1 |Testicular descent. (A) Cranial suspensory ligament (CSL)
and gubernaculum (G) hold the testis. Testosterone (T) and MIS/AMH act
on Wolfﬁan duct (WD) and Müllerian duct (MD). (B) Insulin 3 (Insl3) causes
the gubernacular swelling reaction that holds the testis near the groin
during midgestational growth (8–15 weeks). (C) Calcitonin gene-related
peptide (CGRP) released by the genitofemoral nerve, and under the
control of testosterone, steers the migrating gubernaculum to the
scrotum.
surge of gonadotropins and androgens is known as“mini-puberty”
(Job et al., 1988; Hadziselimovic and Zivkovic, 2007). As andro-
gen levels subside there is a surge in production of MIS/AMH by
Sertoli cells, which peaks at 6–12 months, but remains high then
until puberty when serum levels fall (Baker et al., 1990; Yamanaka
et al., 1991; Aksglaede et al., 2010; Figure 2).
ABNORMAL POSTNATAL DEVELOPMENT IN UDT IN
HUMANS
Failure of the ﬁrst or second phase of testicular descent leads to
congenital cryptorchidism. The causes of UDT remain largely
unknown with some authors suggesting a primary testicu-
lar hormonal malfunction (Heyns and Hutson, 1995), while
others have suggested a secondary hormonal malfunction, such
a hypothalamic–pituitary axis deﬁciency (Hadziselimovic and
Zivkovic, 2007) or a placental failure to produce chorionic
gonadotropin (Heyns and Hutson, 1995). Based on twin stud-
ies, it has also been suggested that risk factors should be sought in
the intrauterine environment and the maternal genes. However,
another possibility ﬁrst suggested in the eighteenth and nine-
teenth centuries, was that there was an anatomical defect in the
mechanism of descent. With the establishment of endocrinology
in the early twentieth century, these anatomical concepts were
mostly replaced with explanations of hormonal dysfunction, such
as described above (Heyns and Hutson, 1995). However, our own
research over the last 25 years, along with others, has suggested
FIGURE 2 | “Mini-puberty,” with testosterone (T) and MIS/AMH
secreted after birth. Neonatal gonocytes mature into adult dark
spermatogonia between 3 and 9 months of age, and primary spermatocytes
form about 3–4 years. After a period of quiescence, spermatids form about 10
years of age, with the onset on spermatogenesis. Undescended testis (UDT)
interferes with the ﬁrst step.
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that anatomical faults may be a common cause of cryptorchidism
(Backhouse, 1964). Cryptorchidism is associated with other con-
genital abnormalities in less than 20% of the cases, but when
present then most are often related to abnormalities of the mid-
line and the caudal development ﬁeld of the body (Cortes, 1998;
Jensen et al., 2010; Thorup et al., 2010). Two key observations in
favor of this view are the failure to document convincing pri-
mary hormonal defects, as well as the realization that the second
phase of descent is a very complex anatomical process, that is
likely to be prone to subtle anomalies (Amann and Veeramacha-
neni, 2007; Thorup et al., 2012). This is further supported by the
fact that the anomaly most often occurs unilaterally, and in cases
where associatedWolfﬁanduct and/or ureteric budmalformations
are present, these are predominantly found ipsilaterally (Cortes
et al., 1998a).
If something goes wrong with migration of the gubernaculum
from the external inguinal ring in the groin across the pubis and
into the scrotum, the initially normal postnatal testis is retained
deep to the inguinal fat pad, which is an effective insulator, keep-
ing the UDT at 34–37◦C (Mieusset et al., 1993), rather than the
normal scrotal temperature of 33◦C, and this is believed to trigger
the progressive postnatal testicular dysfunction, as the postnatal
testis function is only optimal at 33◦C (Zorgniotti, 1991). The
exquisite temperature sensitivity of the testis has been well doc-
umented for a long time, but is currently not a fashionable area
of research in this era of molecular biology. However, the phe-
nomenon has been solidly proven despite the genetic regulation of
it not being fully described. This abnormal postnatal development
in the testis also leads to inhibited postnatal androgen production
(Raivio et al., 2003) and MIS/AMH production at 6–12 months of
age (Yamanaka et al., 1991).
The net effect of cryptorchidism is germ cell loss, leading
to infertility (Mengel et al., 1974; Hadziselimovic, 1985). This
has been well described in many long-term outcome studies in
men with a previous history of cryptorchidism in childhood
(Cortes, 1998; Gracia et al., 2000; Cortes et al., 2001; Vincardi
et al., 2001). However, the cause for this germ cell loss and
its timing have remained elusive until relatively recently. In the
1950s, orchidopexy was recommended in boys aged 10–15 years
if the cryptorchid testes failed to descend spontaneously into
the scrotum at the onset of puberty (Gross and Jewett, 1956;
Vincardi et al., 2001). This recommendation was based on the
clear observation that a signiﬁcant number of cryptorchid testes
descended spontaneously at puberty. In addition, it was assumed
that germ cell development was totally quiescent in childhood.
Indeed, it was thought that the testis was effectively in “sus-
pended animation” until the onset of spermatogenesis in early
puberty.
Current long-term follow-up studies of men with a previous
history of cryptorchidism show a 5- to 10-fold increase in malig-
nancy risk (Whitaker, 1988; Wood and Elder, 2009). However, it
is easy to forget that because of the very long lag-time (i.e., 30–
40 years) between intervention and measurement of the outcome,
in this case development of testicular malignancy, that the age
of orchidopexy in most of these studies in the current literature
is about 5–15 years of age. This has led to the widespread view
in adult endocrinology and oncology that orchidopexy is unable
to prevent development of cancer in men (Gracia et al., 2000).
However, the age for orchidopexy is now much younger, and it
remains to be seen whether this will alter outcomes in adulthood.
Recent studies actually indicate that operation for cryptorchidism
at a young age lowers the risk of testicular cancer in adulthood
(Pettersson et al., 2007).
Meanwhile, in pediatrics, it ﬁrst became apparent in the 1970s
that degeneration of the UDT was occurring in early childhood
(Mengel et al., 1974). Initially it was noted that there was macro-
scopic atrophy of the testis in early primary school years leading
to the view that maybe orchidopexy should be done in 5- to
6-year-old boys rather than at 10–15 years, based on the assump-
tion that this might prevent the obviously visible development of
atrophy. During the 1970s and early 1980s there was histological
evidence accumulating of degeneration visible in boys of 2 years
of age with UDT, leading to the recommendation in pediatric
surgery that orchidopexy might be optimally done in 2-year-old
boys (Hadziselimovic et al., 1975). It was then appreciated that
there were signs of early degeneration in the testis on electron
microscopy at about 12 months of age (Hadziselimovic, 1985;
Figure 3).
Furthermore, it was reported that all UDT harbored germ cells
at the time of birth, but the number of germ cells was decreased in
about one-fourth of cryptorchid newborns (Cortes, 1998). Lack
of germ cells has been reported from 12, and especially from
18 months of age, and therefore surgery has been recommended
before 12 or 18 months of age (Ritzen et al., 2007).
Recent studies have implicated the very ﬁrst phases (i.e., in the
ﬁrst year) of postnatal germ cell development in the etiology of
the subsequent infertility and risk of malignancy. However, we
ﬁrst need to describe normal germ cell development so that the
effects of cryptorchidism can be understood in context.
NORMAL GERM CELL DEVELOPMENT
Around 4–6 weeks of gestation within the embryonic urogenital
ridge the primitive gonad forms on the anteromedial surface of
the middle kidney or mesonephros. Primordial germ cells form
from endodermal cells in the caudal edge of the yolk sac stalk,
and then migrate into the embryonic celom around the wall of
the midgut and into the urogenital ridge, eventually colonizing
the ambisexual gonad and differentiating into gonocytes. By 22
weeks of gestation, these primitive germ cells mature into fetal
spermatogonia (Hadziselimovic, 1983). Mesenchymal cells in the
7- to 8-week ambisexual gonad surrounding the arriving germcells
form the Sertoli cells with the onset of sexual differentiation to
create the testicular cords, inside a basement membrane. Outside
the cords some mesenchymal cells form Leydig cells and begin
hormone synthesis to produce androgen and insulin-like hormone
3 (INSL3), while others form into myoepithelial cells around the
cords.
At birth, the fetal spermatogonia or neonatal gonocytes are
located in the center of the spermatic cords. Throughout child-
hood it appears that the germ cells remained in the center of the
cords, and seemed to be in “hibernation” until the onset of sper-
matogenesis at puberty, as there was little histological change in
their appearance or location. However, in recent years, it became
apparent that by 3–4 years of age the cell in the center of the
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FIGURE 3 |The age at which orchidopexy has been advocated since the
1950s. Reproduced with modiﬁcations from Hutson and Beasley (1992).
testicular cords is a primary spermatocyte, rather than a neonatal
gonocyte (Hadziselimovic, 1983).
Recent studies show that the neonatal gonocyte migrates
between the Sertoli cells to the periphery of the cord between
3 and 9 months of age, or 2 and 6 days of age in mice (Drumond
et al., 2001; Huff et al., 2001b), where it comes in contact with the
basement membrane. These factors trigger transformation into
type-A spermatogonia, which line the basement membrane, dis-
placing the adjacent Sertoli cells. The regulatory factors involved
in this transformation are mostly unknown (see below), although
platelet-derived growth factors (PDGF) B and D, and also PDGF
receptor-beta (PDGFR-β) have been implicated (Basciani et al.,
2008, 2010). Inhibition of PDGFR-β tyrosine kinase activity in
the ﬁrst week postnatally in a mouse causes a severe reduction in
the proliferation of gonocytes and increases their apoptosis (Bas-
ciani et al., 2008, 2010). Type-A spermatogoniamature into type-B
spermatogonia, then migrate back into the center of cord again by
3–4 years, to become primary spermatocytes.
Alongside these studies of early postnatal germ cell develop-
ment have been studies searching for the potential stem cell of
spermatogenesis, with the aim of using these stem cells for recol-
onizing the infertile testis (Brinster, 2007; Waheeb and Hofmann,
2011). Based on morphological criteria, human spermatogonia
have been classiﬁed as dark type-A (Ad), pale type-A (Ap), and
type-B. Ad-spermatogonia have nuclei showing a homogeneous,
dark stainable chromatin and one or more clear cavities of vacuole
like appearance (Clermont, 1963). The type-A spermatogonium
has become the likely stem cell of spermatogenesis (de Rooij and
Russell, 2000; Drumond et al., 2001; Biers and Malone, 2010).
Interestingly not all neonatal gonocytes transform into type-A
spermatogonia, so that by 1–2 years of age the total germ cell
number is less than half that at birth (Hadziselimovic, 1983). The
remaining gonocytes are thought to undergo apoptosis, or pro-
gramed cell death, so that by 2 years of age there are none left
in the testis (Huff et al., 2001b). This process can be seen read-
ily in the postnatal rat testis, as signs of apoptosis are rare until
day 3, but by day 4 analysis shows that one-third of them are lost
(Roosen-Runge and Leik, 2000).
THE SPERMATOGENIC STEM CELL
As neonatal gonocytes seem to differentiate into unipotent stem
cells for subsequent spermatogenesis, their change in appearance,
locationwithin the cord, and function suggest dramatic changes in
germcellular physiology. These changes are regulatedby aprecisely
coordinated expression of key proteins, some of which are known.
In early embryos, germ cells and pluripotent embryonic stem
cells can form any type of cell. However, as development proceeds,
the ability of germ cells to form different cells becomes restricted.
In testes a subpopulation of germ cells retain the ability to dif-
ferentiate, but only as unipotent spermatogenic stem cell (SSCs;
Hofmann et al., 2005).
Huckins and Oakberg have proposed a widely accepted model
for spermatogenic development which is useful to describe here
(Huckins, 1971; Oakberg, 1971; de Rooij and Russell, 2000). In this
model, single type-A spermatogonia are the putative SSCs, which
can self-renew, while paired type-A spermatogonia are differen-
tiating paired daughter cells connected by an intercellular bridge.
Paired type-A spermatogonia divide into chains of aligned cells,
which then become type A1, A2, A3, and then A4 spermatogonia.
The latter cells (A4) divide to form intermediate spermatogonia
and the type-B spermatogonia. Type-B cells then divide to form
primary spermatocytes that enter meiosis (Figure 4). All these
steps are regulated by growth factors from Sertoli and possibly
the peritubular myoid cells (Skinner, 1991; Jegou, 1993). A recent
morphological study (Drumond et al., 2001) showed that postna-
tal development of type-A spermatogonia may occur more rapidly
than in mature spermatogenesis.
The type-A spermatogonia and SSCs have been shown recently
to express a range of differentmarkers (Figure 5). Undifferentiated
SSCs express the integrins β-1 andα-6 (Shinohara et al., 1999), and
the receptors for glial-derived neurotrophic factor (GDNF), such
as GDNF family receptor alpha-1 (GFRα-1) and receptor tyrosine
kinase (RET) (de Rooij and Russell, 2000). In addition undiffer-
entiated SSCs express Zbtb-16 (previously known as Plzf; Buaas
et al., 2004; Costoya et al., 2004). Once SSCs start to differentiate,
they begin expressing a range of different markers, including c-Kit,
the receptor for stem cell factor (Besmer et al., 1993; Yoshida et al.,
2006). They also express Sohlh1 and Sohlh2, as well as neurogenin
3 (Ballow et al., 2006; Filipponi et al., 2007; Hao et al., 2008). As can
be seen from this brief overview,most of whatwe knowabout SSCs
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FIGURE 4 | Postnatal germ cell development in humans. (A) Gonocytes
migrate from the center of the cords to the basement membrane around 6
months, and become type-A spermatogonia. By 3–4 years of age the center
of the cords becomes recolonized with primary spermatocytes. (B) Numbers
of germ cells/tubule in a normal testis and undescended testis (UDT) relative
to age in years. Note the normal fall in total numbers between birth and 2
years, but failure of this to recover in UDT. The shaded area shows the normal
range and the dotted lines show the average numbers.
FIGURE 5 | Germ cell development in the first week postnatally in the rat, showing the germ cells labeled with MVH (mouse homolog of Drosophila
Vasa), and the Sertoli cells labeled with MIS/AMH (bar = 10 μm). (A) Day 0, (B) Day 4, (C) Day 6, (D) Day 10.
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comes from studies of adult spermatogenesis or stem cell research,
rather than a direct study of the type-A spermatogonium in the
postnatal testis.
ABNORMAL GERM CELL DEVELOPMENT
All cryptorchid testes of newborns contain germ cells, although
in some testes the number is impaired compared to normal.
So signiﬁcant deranged germ cell development in cryptorchid
testes probably begins postnatally, except in the dysgenetic testis
in disorders of sex development (DSD). The ﬁrst step to fail is
transformation of gonocytes into type-A spermatogonia, which
is delayed or interrupted. Evidence for this disruption is found
in the persistence of large numbers of gonocytes in the center of
the testicular cords well beyond 6 months of age (Figure 6), and
a decreased number of type-A spermatogonia (Hadziselimovic
et al., 1986; Huff et al., 1989, 1991). After the ﬁrst year or so the
number of spermatogonia decrease, while those that remain are
gonocyteswith bizarre nuclei (Hadziselimovic, 1983). By 3–4 years
of age the abnormality has become evenmore obvious, with failure
of primary spermatocytes to appear (Huff et al., 1989).
The abnormally high temperature of the cryptorchid human
testis is considered by most authors to be the cause of this germ
cell maldevelopment. Considerable studies have been performed
in various animal models showing that heat stress leads to a com-
bination of both indirect and direct effects on the germ cells,
causing impaired transformation and maturation as well as inhib-
ited apoptosis. This thermal injury is mediated by reactive oxygen
species and certain heat-shock proteins, which damage the germ
cells as well as Sertoli cells (Setchell, 1998; Zini et al., 1999; Ivell
and Hartung, 2003).
Defective transformation of gonocytes into type-A dark sper-
matogonia between 3 and 9 months of age correlates with
abnormal sperm counts after puberty (Hadziselimovic and Her-
zog, 2001a; Huff et al., 2001a). In cases of no adult dark
spermatogonia, the age of orchidopexy has not affected a
poor result for spermatogenesis in adulthood, at least so far
FIGURE 6 | Abnormal persistence of gonocytes beyond 6 months of
age in a boy with cryptorchidism.The germ cells are labeled with MVH
(mouse homolog of Drosophila Vasa), and the Sertoli cells are labeled with
MIS/AMH (bar = 10 μm).
(Hadziselimovic and Herzog, 2001b). The degree of risk of sub-
sequent infertility can be quantitated, as it is almost inevitable
if there are fewer than 1% of the number of spermatogonia per
tubular cross-section, seen in biopsies from age-matched controls
(Cortes et al., 1996). Under normal physiological circumstances,
the surge of gonadotropins and testosterone, and possibly other
as yet unknown hormones, occurs at 2–3 months of postnatal
age. This hormonal surge stimulates the gonocytes in the testis
to develop into adult dark spermatogonia. In cryptorchidism
there has been reported evidence for a beneﬁcial role of adju-
vant gonadotropin-releasing hormone to improve fertility in UDT
(Biers and Malone, 2010). It has been questioned as a general rec-
ommendation (Hutson, 2010). Recently there have been described
different groups of cryptorchid boys, and if the patients at the time
of surgery have a decreased number of germ cells and/or inhibin B
andno compensatory increase in gonadotropins, then supplemen-
tary hormonal treatment may be indicated after early surgery for
UDT (Thorup et al., 2012). It has been suggested that antisperm
antibodies may be involved in the germ cell loss in cryptorchidism,
but there is no evidence for postpubertal antibodies after previous
surgery in childhood for cryptorchidism (Mirilas et al., 2003). All
these studies suggest that the postpubertal poor fertility is likely
to be caused by an abnormally small pool of SSCs, the type- A
spermatogonia.
The risk of cancer after cryptorchidism in infancy is less easily
correlated with abnormal germ cell development after birth. It has
been well described that the risk of developing a testicular germ
cell cancer is about 5- to 10-fold higher in men with a previous
history of cryptorchidism compared with those with descended
testis in childhood (Chilvers et al., 1986; Giwercman et al., 1987;
Moller et al., 1998; Wood and Elder, 2009). Testicular germ cell
tumors are extremely common, affecting 1% of young men (Rorth
et al., 2000).
The common precursor of these tumors is the premalignant
carcinoma in situ (CIS) cell, which is proposed to be a fetal germ
cell that failed to differentiate, and remains, dormant in the testis
until after puberty (Skakkebaek et al., 1982). The evidence sup-
porting this view comes from the many similarities between CIS
cells and fetal gonocytes, which share many markers and mor-
phological characteristics (Holstein and Korner, 1974; Skakkebaek
et al., 1982; Rorth et al., 2000; Rajpert-De Meyts et al., 2003). CIS
cells may well originate during fetal development in DSD, where
the germ cell physiology is deranged by the underlying genetic
anomaly. By contrast, this seems less plausible in cryptorchidism
if the maldescent is caused by extraneous mechanical defects.
In cryptorchidism, therefore, the CIS cell may arise from the
neonatal gonocytes, which are abnormally abundant. The gono-
cytes have pluripotent stem cell properties, which if they persist
until after puberty, with or without mutation, may develop into
cancer.
Carcinoma in situ cells are more likely to be present where there
are speciﬁc genetic defects, and there may be developmental arrest
(Skakkebaek et al., 1987, 1998; Honecker et al., 2004). Expression
proﬁles of CIS cells and embryonic stem cells are very similar,
which supports the view of CIS being a multipotent stem cell
(Almstrup et al., 2004). A unifying hypothesis has been proposed
to link testicular maldevelopment, testicular cancer, low sperm
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counts, and cryptorchidism, known as the testicular dysgenesis
syndrome (TDS; Asklund et al., 2004).
Carcinoma in situ is more common in men with previous
cryptorchidism, and is documented in 2–3% of adult patients
(Giwercman et al., 1987, 1989). However, the prevalence of CIS
is higher in those men with macroscopic testicular atrophy (Har-
land et al., 1998) or those with bilateral cryptorchidism (Swerdlow
et al., 1997). Where cryptorchidism is unilateral, the contralateral
descended testis has a slightly increased risk of cancer (Forman
et al., 1994). Not surprisingly, cancer risk is also increased where
testes were intra-abdominal, the genitalia were abnormal or there
was a known abnormal karyotype (Cortes et al., 1999).
In a pediatric collective series of six studies, the risk of CIS in
2800 boys with cryptorchidism was 0.36% only (Cortes, 1998).
When compared to higher incidence data from adults these pedi-
atric ﬁgures support the hypothesis that the characteristics of
CIS cells and later testicular cancer develops over time, and are
not present from fetal life. Generally CIS in pediatric series is
described in later childhood (Cortes et al., 1999). However, in
this paper we present a 12-month-old boy with suspected CIS in
bilateral cryptorchid testes (Figure 7). It has to be emphasized
that positive immunohistochemical markers indicating CIS in the
adult testis do not have such predictive value when applied to the
childhood cryptorchid testis. Positive staining by such markers of
persistent fetal germ cells is seen in almost half of the cryptorchid
testes of boys younger than 5 years (Thorup et al., 2012). Presence
of placental alkaline phosphatase (PLAP)-positive immunohisto-
chemical stained gonocytes in bilateral cryptorchid testes of infant
boys indicates the ability of delayed germ cell transformation and
a preserved good fertility potential (Cortes et al., 2012). Further
research in this ﬁeld is therefore needed.
It has been suggested that testicular biopsy itself at the time
of orchidopexy is a risk factor for postpubertal cancer (Swerdlow
et al., 1997). In the review by Swerdlow et al. (1997) only 9% of the
operated testes were subjected to biopsy, consistent with a possible
selection bias by the surgeon, who may have only picked the more
atrophic testes for analysis. This view is supported by a large
study of 830 cryptorchid patients having routine biopsy, where
there was no correlation between the biopsy itself and subsequent
malignancy (Moller et al., 1998).
Some authors have suggested that adolescents with a previous
history of cryptorchidism and orchidopexy should be offered a
biopsy to identify if CIS is present, before invasion has occurred
(Giwercman et al., 1989). Alternative screening methods such as
reliable blood or semen analysis are not yet available, although
testicular ultrasonography may have a place (Holm et al., 2001).
Ultrasonography shows a relationship between microlithiasis and
CIS, but the signiﬁcance of this is uncertain (Lenz et al., 1996),
particularly as more recent studies of testicular microlithiasis
show that it is quite common in normal adolescents (Goede et al.,
2009). CIS is also associated in some patients with cryptorchidism
with multinucleated germ cells, consistent with aberrant germ cell
development (Cortes et al., 2003).
There is inconclusive evidence that an early age of surgery
leads to a reduction in risk of cancer (Pike et al., 1986; Swerd-
low et al., 1997; Wood and Elder, 2009). However, because of
the long lag-time between treatment and outcome, the age at
FIGURE 7 |Testicular tissue from a 12-month-old boy with bilateral
cryptorchidism. Carcinoma in situ (CIS) is suspected. (A) H&E staining:
Sertoli cells are normal and the germ cell number is at the upper range for
age. Some germ cells have two nuclei, and some nuclei have irregular
morphology and some nucleolus. A microlith is clearly seen within a tubule.
(B) Strong PLAP expression seen in all germ cells. (C) OCT4 expression in
germ cells also in the periphery of tubules, which is not often seen so
impressively in most cryptorchid testes at a similar age.
surgery in these follow-up studies averaged more than 2 years
old. In the context of the proposal, that early germ cell develop-
ment is the key, these long-term results are consistent with either
no effect of age at all, or with the suggestion that lack of neonatal
gonocyte transformation and impaired apoptosis predisposes to
malignancy.
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One of the problems that has bedeviled the relationship
between cryptorchidism and malignancy is the lack of an animal
model, as rodents with UDT do not develop testicular tumors.
Another problem is that evidence is accumulating that there are
some testes that become undescended after birth, and that this
group, now known as acquired cryptorchidism, have a different
risk of malignancy compared with congenital UDT.
ACQUIRED CRYPTORCHIDISM
After birth, the distance from the inguinal canal to the scrotum
increases from 4–5 to 8–10 cm in early adolescence (Smith et al.,
1989). This means that the spermatic cord must double in length
between birth and puberty (Hutson et al., 2010). We have pre-
viously proposed that failure of this elongation is the cause of
ascending testes or acquired UDT (Hutson and Hasthorpe, 2005),
and this is the likely explanation for many children still having
orchidopexy at 5–10 years, despite recommendations for surgery
in infancy (Donaldson et al., 1996).
Realization that there are two types of UDT has triggered a
re-evaluation of the cause and effect of UDT. First, it is becom-
ing apparent that men who had untreated, acquired UDT have
no increased cancer risk, but still have impaired fertility (Cortes
et al., 1998b). Secondly, it means that current long-term follow-up
studies in adults are likely to contain a mixture of patients with
both congenital and acquired UDT (Bonney et al., 2008), making
their interpretation difﬁcult.
Investigators have puzzled over why UDT in rodents caused
infertility but not cancer, as in humans. We propose that this
is the result of differences in timing in when the testis reaches
the low-temperature scrotal environment. In humans, the testis
is at 33◦C from birth, so that congenital UDT has the potential
to damage neonatal gonocytes by high temperature. By contrast,
rodent testes only reach the scrotum after 12 days of age (Bergh,
1991), which is well after normal gonocyte transformation and/or
apoptosis is complete (Figure 8).
Undescended testis in rodents, therefore, is actually a model
for acquired UDT in humans, with high temperature damaging
the SSCs, but with no cancer risk as the gonocytes will have
developed or disappeared normally. Once this key difference in
timing of testicular descent is understood, extrapolation between
rodentmodels and thehuman situation is straightforward, as other
key processes are the same. Both species groups have a postnatal
“mini-puberty” at 3–6 months in humans and 2–4 days in mice,
when there is burst of testicular hormones and cytokines which
are likely to be involved in gonocyte development. In addition,
gonocyte migration from the center of the cords to the basement
membrane to form SSCs is similar in both timing and general
morphology.
A temperature difference between undescended and normally
descended testes in rats is not present until after 12 days of age
(Zorgniotti, 1991), which is well after the gonocytes should have
transformed normally into SSCs or have undergone apoptosis. If
excess persisting gonocytes are the cause of CIS and cancer in
cryptorchidism, then none will be present in the testis when the
temperature becomes abnormal in rodent UDT, consistent with
the lack of cancer in these models. However, the high temperature
of the UDT will still damage SSCs leading to subsequent infertility
(Figure 8).
FIGURE 8 |Testicular temperature in humans and rodents.
(A) Human gonocytes mature in the ﬁrst year when the testicular
temperature is 33◦C. Congenital UDT have abnormal temperature
early, which interferes with gonocyte development. By contrast,
acquired UDT only interferes with subsequent survival of stem cells. (B) In
rodents, gonocytes mature before a change in temperature occurs, so that
gonocyte development is unaffected, similar to acquired UDT in
humans.
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CONCLUDING REMARKS
All the evidence available points to early germ cell matura-
tion being the “missing link” in the disconnection between
the timing of orchidopexy and the subsequent risks of both
infertility and malignancy. This suggests that infants getting
really early operation may have signiﬁcantly improved out-
comes, although this remains hypothetical. Furthermore, in
some cases supplementary hormonal treatment may be needed
to achieve the normal transformation to adult dark spermato-
gonia.
The key role of heat in interfering with the signaling that con-
trols both gonocyte transformation and/or apoptosis needs to be
reinvestigated fully, as it is likely to lead to changes in clinical
management of congenital cryptorchidism.
The recognition of acquired UDT as a real clinical entity has
not only informed our understanding of the possible management
in children, but also provided an insight into why rodent animal
models of cryptorchidism do not demonstrate testicular cancer.
In both circumstances, the abnormal temperature affects the testis
well after gonocyte maturation or apoptosis is complete, so that
secondary heat shock depresses stem cell function alone, leading
to infertility.
The next few years should help to shed light on these new
developments further, so that we can determine the optimal treat-
ment, which may include a differentiated treatment strategy for
different groups of cryptorchid boys. Equally, the risk of infer-
tility and testicular cancer may not be the same in all boys with
cryptorchidism.
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